Evolus (EOLS) Amortizatization of Intangibles (2019 - 2021)
Evolus (EOLS) posted Amortizatization of Intangibles of -$272000.0 for Q4 2021, down 3985.71% on a QoQ basis from $7000.0 in Q4 2020, and down 3985.71% year-over-year from $7000.0 in Q4 2020.
Evolus (EOLS) Amortizatization of Intangibles (2019 - 2021) Analysis & Trends
Evolus' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$272000.0 for Q4 2021.
- Quarterly Amortizatization of Intangibles fell 3985.71% year-over-year to -$272000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$272000.0 (down 163.7% YoY) and the FY2021 annual result came in at -$272000.0, down 163.7% from the prior year.
- Amortizatization of Intangibles was -$272000.0 for Q4 2021 at Evolus, down from $7000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $466000.0 in Q2 2019 and bottomed at -$272000.0 in Q4 2021.
- A 3-year average of $132555.6 and a median of $126000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2020 — Amortizatization of Intangibles surged 40.83% — and 2021, when it plunged 3985.71%.
- Evolus' Amortizatization of Intangibles stood at $126000.0 in 2019, then tumbled by 94.44% to $7000.0 in 2020, then plunged by 3985.71% to -$272000.0 in 2021.
- Business Quant data shows EOLS's Amortizatization of Intangibles at -$272000.0 in Q4 2021, $7000.0 in Q4 2020, and $30000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Evolus | 403.51 Mn | 353.71 Mn | 48.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -272,000.00 |
| Dec 31, 2021 | -272,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Dec 31, 2019 | 126,000.00 |
| Dec 31, 2019 | 126,000.00 |
| Sep 30, 2019 | 326,000.00 |
| Sep 30, 2019 | 326,000.00 |
| Jun 30, 2019 | 466,000.00 |
| Jun 30, 2019 | 466,000.00 |
| Mar 31, 2019 | 120,000.00 |
| Mar 31, 2019 | 120,000.00 |